Moreover, PX478 has been reported to inhibit HIF-1α deubiquitination, resulting in a decrease of HIF-1α protein levels due to the accumulation of its polyubiquitinated form and antitumor effects in HT29 tumor xenografts [107,108]. Here, HIF1A is linked to neoplasm.